Natco Pharma Scores Big with US Nod for Generic Drug

Hey, listen up, Natco Pharma just scored a major victory! They snagged the thumbs up from the US health regulators for their generic cancer-busting champ, Erdafitinib! This powerhouse comes in 3 mg, 4 mg, and 5 mg to take on that pesky urothelial carcinoma. And guess what? Their stock is flexing its muscles, up 3.39 percent at Rs 851.45! Can you smell what Natco's cooking?